Parton - FABA
Dr. M. K. Bhan
Former Secretary to Govt. of India, Department of Biotechnology, New Delhi.
Patron - FABA
Mr B P Archarya
IAS, Principal Secretary Tourism and Culture, Government of Telangana State
Advisor - FABA
Prof Late K V Raghvan
INAE Distinguished Professor ,Indian Institute of Chemical Technology (IICT), Hyderabad.
Advisor - FABA
Prof Dr Seyed E Hasnian
Distinguished Professor of Biological Sciences at the Indian Institute of Technology, Delhi.
Advisor - FABA
Ms. Sheela Bhide
President - FABA
Dr. Anand Govindaluri
Dr. Anand Govindaluri is the Founder & Chief Executive Officer of Govin Capital (govincapital.com), a Singapore-based early-stage investment company. He is also the Founder of Startup Accelerator India, Visakhapatnam, a technology accelerator focused on Digital Health & Technology that has expanded in Pune & Lucknow. Anand has 17 years of active investment management experience in the healthcare and technology sectors and is a recipient of Dr A.P.J. Abdul Kalam Award for Innovation & Entrepreneurship, by the Honourable Governor of Uttar Pradesh, India. Prior to GOVIN, Anand served as the Senior Vice President & Head of the Investment & Spin-Off Management Division at ETPL, A*STAR, Singapore (2009-2012). At ETPL, he led a team to manage a portfolio of 40 Startups from A*STAR in the fields of Medtech, Infocomm, & Engineering. In addition, he also actively organized several Technopreneurship & Investor workshops for researcher and scientific community in Singapore.
Executive President - FABA
Dr. P. Reddanna
Prof. Pallu Reddanna, Ph.D, serves as a Member of Advisory Council at Saamya Biotech (India) Limited. Prof. Reddanna, has also served as the Dean of School of Lifesciences, University of Hyderabad, India. He worked as a Lecturer at S V University, Tirupati before joining as Reader at the university of Hyderabad and became full Professor in 1998. He has several Research projects supported by Govt. of India ( Dept. of Biotechnology, CSIR and DST) and Industries (NATCO Pharma, Laila Impex, Onconova â€“ USA and AOARD â€“ Japan). Prof. Reddanna published over 150 original research papers in both National and International journals, filed three patents for three inventions, and guided 30 students for Ph.D and 100 students for M.Sc. projects. He is a member of several professional Societies and Advisory Committees, and organized many national and international symposia. Prof. Reddanna is the recipient of Royan International Foundation, Chemtech Foundation and Rockefeller Foundation Biotechnology Career Awards. Prof. Reddanna holds a Ph.D degree and is a reputed teaching scientist leading a research group in the field of Biotechnology.
Vice President - FABA
Shakthi Nagappan serves as the Director (Life Sciences and Pharma) for the State Government of Telangana and is in-charge of the Hyderabad Pharma City initiative of the Government, which is one of the biggest Greenfield projects of its nature in Asia, being developed at an area of 19000 acres at international standards. He also serves as the Chief Executive Officer of BioAsia, the flagship international initiative of Telangana Government. Prior to this role, he was working with the biotech division of International Crop Research Institute (ICRISAT), an organization established by the United Nations. His focus was on building strategic partnerships and stakeholder engagement, project management, regulatory compliance besides operations. He is a recipient of Young Scientist Award, Award of Merit from His Excellency the Governor of Tamil Nadu, National Children Science Congress Award, and the All India Biotech Association Award for Excellence in Life Sciences Promotion
Secretary General - FABA
Pof. Vijay Kumar Kutala
Prof. Vijay Kumar Kutala is serving as Additional Professor in Department of `Clinical Pharmacology & Therapeutics. He is also the Editorial Board member, Gene (Elsevier) Journal, Advisor Board Member, Am J Current Genetics, Autoimmune Diseases and Therapeutic Approaches. He as published more than 100 research papers in reputed journals and has authored 3 books. He was awarded with the prestigious James V Warren Most Outstanding Award, Ohio State University, USA in year 2004. Prof. Vijay Kumar has held various crucial positions in various associations in the past including, National Academy of Medical Sciences (NAMS), New Delhi, Society for Free Radical Research-India, Secretary General, Indian Academy of Biomedical Sciences.
EC Member - FABA
Dr.P Ratnakar is the Vice President & Global Practice Head- Life Sciences and Medical Devices at Tech Mahindra which is a leading provider of digital transformation, consulting and business re-engineering services and solutions. He is responsible for the Global Practice, alliancing and partnerships, Analyst relationships and Co-innovation with start-ups and partners.
He served as Director and Head of Strategic Planning for Dr.Reddyâ€™s Laboratories for 18 years. He managed various functions in the Product Portfolio Management, Strategic Planning, market intelligence and commercial Operations.
He is Member -Appraisal Committee of BioNEST (Bio-incubator Nurturing Entrepreneurship for Scaling Technologies) and is also serving as a Member- Board of Studies, JNTU.
He holds a Ph.D degree in Management Sciences from JNTU.
EC Member - FABA
Dr. Suresh Poosala
Dr. Suresh Poosala was a Principal Consultant and Science Business Development at the Jackson Laboratory before he founder OncoSeek Bio. He is also a council member of Laboratory Animal Care Facilities Accreditation and was also a member of the senior leadership team at Bristol-Myers Squibb India. He received his PhD from Iowa State Univerisity in Veterinary Pathology and Immunology in the year 1994.
EC Member - FABA
Dr. Mandar Kulkarni
Dr. Mandar Kulkarni served as the Chief Technology Officer at Cancer Genetics Inc., before he became the Chief Executive Officer at VCR Park. Dr. Kulkarni spearheaded the development of an oncology-focused knowledge base that included genomic information geared toward facilitating the personalization of treatment for Indian populations. He has an in-depth cancer research background, both as a manager and as a scientist. Prior to joining CG India, Kulkarni was Head of molecular biology and genomics at Sandor Lifesciences, where his team designed and executed next-generation sequencing, bioinformatics, and microarray initiatives. Kulkarni was also a senior scientist at M/Z Diagnostics where he developed and clinically validated a diagnostic assay for rapid detection of multi-drug resistant bacterial infections.Dr. Kulkarni received his Bachelor of Science degree from Pune University and the University of Wisconsin and earned a doctorate degree from Purdue University. He completed his postdoctoral training at Yale School of Medicine.
EC Mebber - FABA
Dr. Markandeya Gorantla
Dr. Markandeya is Chairman and Managing Director of the company and oversees business development, Production and research and development. He has varied experience in pre-clinical and clinical research for the past 10 years at EPR Pharma and Onconova Therapeutics Inc. USA. He was involved in coordinating projects for NCE library synthesis wherein he was instrumental in development of more than 3000 new chemical entities for drug discovery program. He was also involved in manufacturing of Active Pharmaceutical ingredients of clinical trial molecules. He founded ATGC biosolutions in the year 2005 and his work mainly focused on developing semiochemical intermediates for large scale synthesis of Pheromones. In the year 2011 he incorporated ATGC Biotech Pvt. Ltd. for commercializing the research products developed at ATGC Biosolutions as a promoter. Previously Dr. Markandeya has a decade long research experience in high throughput DNA sequencing, Gene Arrays and molecular biology. Also, he is well versed with high-throughput genome technologies. He worked under Rockefeller Foundation Drought Program and developed allele sharing maps of Indian rice cultivars through SNP analysis for drought tolerance. Previously, he has 3 years of Industrial experience in bio-process technologies and holds a M. Tech degree in the field. He is well versed with isolation, characterization of microbial organisms for their beneficial nature.
EC Member - FABA
Dr. Raman Meenakshi Sundaram
Dr. Raman Meenakshi Sundaram served as Senior Scientist (Biotechnology), ICAR-IIRR (formerly known was Directorate of Rice Research), Hyderabad IUSSTF. He was a Post-Doctoral Fellow, at Iowa State University and Cornell University, USA. Prior to which he worked as a Scientist (Sr. Scale; Biotechnology) at, ICAR-IIRR, Hyderabad, and also as USAID-ABSPII Research Fellow, at Cornell University, USA. In 2016, he was awarded the Government of India Award for Biotech Product and Process Commercialization. He is currently Elected Fellow, of National Academy of Agricultural Sciences and is presently working as Principal Scientist (Biotechnology) at Indian Instituteof Research Institute, Hyderabad.
Vice President - FABA (North India)
Mr. Vishal Gandhi is the Founder and CEO of BIORx Venture Advisors Pvt Ltd (BVA) and leads an accomplished team of MBAs, Chartered Accountants and Life -Sciences Domain Experts. The focus of BVA has been on providing Mergers and Acquisitions (M&A) /J.V advisory services, Technology Transfer, Commercial and Technical due diligence and helping clients raise capital. He has provided opinions and reports on over 100 valuations in his career.
Prior to starting his own company, Vishal had a 7 year stint with YES Bank, where he significantly developed the Life Sciences and Healthcare Vertical bringing in business from over 35 significant transactions in the area of M&A/Private Equity /Debt Space. He was extensively involved in financial, technical and commercial due diligence for Bank In -house clients and had worked with various Govt. agencies in conceptualization and implementation of the funding schemes. Some of marquee transactions he worked on includes financing of Indiaâ€™s largest Multi-Specialty single location hospital â€œMedanta Medicityâ€ at NCR- Gurgaon. Vishal has authored/presented 6 Knowledge papers and published few articlesrelated to various facets of Healthcare, Pharmaceuticals and Medical Devices.